Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1974 1
1975 2
1976 35
1977 111
1978 135
1979 192
1980 263
1981 360
1982 405
1983 489
1984 609
1985 721
1986 762
1987 853
1988 1086
1989 1250
1990 1604
1991 1801
1992 2175
1993 2614
1994 3109
1995 3385
1996 3529
1997 3655
1998 3957
1999 4009
2000 4188
2001 4607
2002 4908
2003 5495
2004 5984
2005 6423
2006 6586
2007 6780
2008 7019
2009 7536
2010 8222
2011 8893
2012 9654
2013 10066
2014 9855
2015 10022
2016 9448
2017 9105
2018 8845
2019 8782
2020 8707
2021 8211
2022 7161
2023 6158
2024 1797

Text availability

Article attribute

Article type

Publication date

Search Results

200,804 results

Results by year

Filters applied: . Clear all
Page 1
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, Fasching PA, Crown J, Bardia A, Chia S, Im SA, Ruiz-Borrego M, Loi S, Xu B, Hurvitz S, Barrios C, Untch M, Moroose R, Visco F, Afenjar K, Fresco R, Severin I, Ji Y, Ghaznawi F, Li Z, Zarate JP, Chakravartty A, Taran T, Hortobagyi G. Slamon D, et al. N Engl J Med. 2024 Mar 21;390(12):1080-1091. doi: 10.1056/NEJMoa2305488. N Engl J Med. 2024. PMID: 38507751 Clinical Trial.
Capivasertib: First Approval.
Shirley M. Shirley M. Drugs. 2024 Mar;84(3):337-346. doi: 10.1007/s40265-024-01998-6. Drugs. 2024. PMID: 38388873 Review.
Angiogenic Biomarkers in Preeclampsia.
Burwick RM, Rodriguez MH. Burwick RM, et al. Obstet Gynecol. 2024 Apr 1;143(4):515-523. doi: 10.1097/AOG.0000000000005532. Epub 2024 Feb 13. Obstet Gynecol. 2024. PMID: 38350106 Review.
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Huang L, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang HC, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, Jiang Z, Wang H, Lamour F, Song G, Curran M, Duan C, Lysbet de Haas S, Restuccia E, Shao Z. Huang L, et al. Nat Commun. 2024 Mar 9;15(1):2153. doi: 10.1038/s41467-024-45591-7. Nat Commun. 2024. PMID: 38461323 Free PMC article. Clinical Trial.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Amphiregulin in lung diseases: A review.
Shen C, Fan X, Mao Y, Jiang J. Shen C, et al. Medicine (Baltimore). 2024 Feb 23;103(8):e37292. doi: 10.1097/MD.0000000000037292. Medicine (Baltimore). 2024. PMID: 38394508 Free PMC article. Review.
Targeting RET mutation in medullary thyroid cancer.
Assi T, Tikriti Z, Shayya A, Ibrahim R. Assi T, et al. Pharmacogenomics. 2024 Feb;25(3):113-115. doi: 10.2217/pgs-2023-0234. Epub 2024 Mar 7. Pharmacogenomics. 2024. PMID: 38450459 No abstract available.
200,804 results
You have reached the last available page of results. Please see the User Guide for more information.